Our attorneys also provide the latest updates from the Zantac class action lawsuit (including the disastrous news of the class action judge dismissing all of the federal court Zantac lawsuits. This page was updated on June 1, 2023.
The Zantac litigation continues to move forward in state court.
Bladder cancer has recently become the focus of the ongoing Zantac lawsuit. In this post, we will look at bladder cancer in personal injury lawsuits.
We examine the nature of bladder cancer as a disease and as an injury in medical malpractice, product liability, and other types of tort cases. Our lawyers also discuss the settlement compensation amounts for bladder cancer in tort cases.
Bladder cancer has become a focus of the Zantac lawsuit because the science linking bladder cancer and NDMA is probably stronger for Zantac than any other cancer. These may be the strongest of the five cancers that are being pursued in the Zantac class action lawsuit. So there is a new focus on Zantac bladder cancer lawsuits than we saw earlier in the litigation.
The last two years have been pretty bad for the popular heartburn drug Zantac after testing revealed that it contained significantly high levels of the carcinogen N-Nitrosodimethylamine (NDMA). This led to Zantac being pulled off the shelves of major retailers and eventually a nationwide FDA recall.
Hundreds of individuals have now filed lawsuits against Zantac’s manufacturers. The suits alleged that taking Zantac caused the plaintiffs to develop certain types of cancer. Hundreds more Zantac cancer lawsuits are expected to be filed/tolled in the MDL (which really means the claims are “kinda filed” without all of the formalities).
Lawsuit Information Center